Chylomicron remnant: Difference between revisions
Jump to navigation
Jump to search
Gerald Chi (talk | contribs) (Created page with "__NOTOC__ {{Chylomicron remnant}} {{CMG}}; {{AE}} {{AN}}; {{RT}} == Overview == == Chylomicron remnant historical perspective|Historical P...") |
Rim Halaby (talk | contribs) No edit summary |
||
| (4 intermediate revisions by one other user not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Chylomicron remnant}} | {{Chylomicron remnant}} | ||
{{CMG | {{CMG}} | ||
== [[Chylomicron remnant overview|Overview]] == | == [[Chylomicron remnant overview|Overview]] == | ||
| Line 14: | Line 14: | ||
== Clinical Correlation== | == Clinical Correlation== | ||
===[[High Chylomicron | ===[[High Chylomicron Remnant]]=== | ||
[[High | [[High chylomicron remnant epidemiology and demographics|Epidemiology and Demographics]] | [[High chylomicron remnant pathophysiology|Pathophysiology]] | [[High chylomicron remnant causes|Causes]] | [[High chylomicron remnant prognosis and complications|Prognosis and Complications]] | ||
===[[Low Chylomicron | ===[[Low Chylomicron Remnant]]=== | ||
[[Low | [[Low chylomicron remnant epidemiology and demographics|Epidemiology and Demographics]] | [[Low chylomicron remnant pathophysiology|Pathophysiology]] | [[Low chylomicron remnant causes|Causes]] | [[Low chylomicron remnant prognosis and complications|Prognosis and Complications]] | ||
== Treatment == | == Treatment == | ||
[[Chylomicron remnant medical therapy|Medical Therapy]] | [[Chylomicron remnant primary prevention|Primary Prevention]] | [[Chylomicron remnant secondary prevention|Secondary Prevention]] |[[Chylomicron remnant landmark trials|Landmark Trials]] | [[Chylomicron remnant future or investigational therapies|Future or Investigational Therapies]] | [[Chylomicron remnant medical therapy|Medical Therapy]] | [[Chylomicron remnant primary prevention|Primary Prevention]] | [[Chylomicron remnant secondary prevention|Secondary Prevention]] | [[Chylomicron remnant landmark trials|Landmark Trials]] | [[Chylomicron remnant future or investigational therapies|Future or Investigational Therapies]] | ||
{{Lipoproteins}} | {{Lipoproteins}} | ||
[[Category:Cardiology]] | |||
[[Category:Lipid disorders]] | [[Category:Lipid disorders]] | ||
[[Category:Lipoproteins]] | [[Category:Lipoproteins]] | ||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} | ||
Latest revision as of 03:05, 16 September 2013
|
Chylomicron Remnant Microchapters |
|
Clinical Correlation |
|---|
|
Treatment |
|
Case Studies |
|
Chylomicron remnant On the Web |
|
American Roentgen Ray Society Images of Chylomicron remnant |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Historical Perspective
Classification
Biochemistry
Physiology
Clinical Correlation
High Chylomicron Remnant
Epidemiology and Demographics | Pathophysiology | Causes | Prognosis and Complications
Low Chylomicron Remnant
Epidemiology and Demographics | Pathophysiology | Causes | Prognosis and Complications
Treatment
Medical Therapy | Primary Prevention | Secondary Prevention | Landmark Trials | Future or Investigational Therapies